Skip to main content

Pregabalin

NDC 71610-931 · Aphena Pharma Solutions - Tennessee, LLC

Generic namePregabalin
Dosage formCAPSULE
RouteORAL
Active ingredient(s)PREGABALIN
Strength25 mg/1
DEA scheduleCV
Marketing categoryANDA

Packages

71610-931-30 — 30 CAPSULE in 1 BOTTLE (71610-931-30)

71610-931-46 — 56 CAPSULE in 1 BOTTLE (71610-931-46)

71610-931-53 — 60 CAPSULE in 1 BOTTLE (71610-931-53)

71610-931-54 — 84 CAPSULE in 1 BOTTLE (71610-931-54)

71610-931-60 — 90 CAPSULE in 1 BOTTLE (71610-931-60)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

71610-808 — Pregabalin, 71610-820 — Pregabalin, 71610-845 — Pregabalin, 71610-871 — Pregabalin, 71610-882 — Pregabalin, 71610-887 — Pregabalin, 71610-894 — Pregabalin, 71610-925 — Pregabalin, 71610-926 — Pregabalin, 71610-930 — Pregabalin, 71610-936 — PREGABALIN, 71610-946 — Pregabalin, 71610-947 — Pregabalin, 71610-948 — Pregabalin, 71610-993 — PREGABALIN, 71610-994 — PREGABALIN, 71610-995 — PREGABALIN, 71610-996 — PREGABALIN, 71610-997 — PREGABALIN, 71610-998 — PREGABALIN, +519 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels